Completed

STAMPSmoking Treatment and Anxiety Management Program

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Cognitive Behavioral Therapy for smoking cessation

+ Cognitive Behavioral Therapy for smoking cessation and anxiety sensitivity reduction.

Behavioral
Who is being recruted

Behavior+4

+ Mental Disorders

+ Tobacco Use Disorder

From 18 to 45 Years
+11 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: January 2008
See protocol details

Summary

Principal SponsorFlorida State University
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 2008

Actual date on which the first participant was enrolled.

The Smoking Treatment and Anxiety Management Program (STAMP) is a treatment program focused on helping people manage their anxiety while quitting smoking. The study involves coming in to our clinic for 4 treatment sessions, with follow-ups for up to 2 years (a week 1, week 2, month 1, month 3, month 6, year 1, and year 2 follow-up). Participants will be paid $142.50 for their full participation as well as receive 6 weeks of free nicotine replacement patches.

Official TitleSmoking Treatment and Anxiety Management Program
Principal SponsorFlorida State University
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

378 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 45 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

BehaviorMental DisordersTobacco Use DisorderHealth BehaviorSmoking CessationSubstance-Related DisordersChemically-Induced Disorders

Criteria

5 inclusion criteria required to participate
Anxiety Sensitivity Index greater than 15

Daily smoker for at least 1 year

Less than 45 years old

Currently smoke at least 8 cigarettes per day

Show More Criteria

6 exclusion criteria prevent from participating
History of panic disorder

Psychotropic medication use (if not stable for 3 months)

History of significant medical condition

Current use of smoking cessation pharmacology

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
Cognitive Behavioral Therapy for smoking cessation.

Group II

Experimental
Cognitive Behavioral Therapy for smoking cessation plus anxiety sensitivity reduction.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Anxiety and Behavioral Health Clinic

Tallahassee, United StatesOpen Anxiety and Behavioral Health Clinic in Google Maps
CompletedOne Study Center